Speaking at a cancer summit at Howard University in Washington, Biden made an impassioned plea for increased urgency in the fight against cancer.
The event was part of a national day of action involving hundreds of researchers, patient advocates and data experts across the country.
Biden's son Beau died last year at age 46 from brain cancer, something Biden said helps inform his passion for the project.
Among proposals intended to bypass inefficiency at the federal level, he announced the formation of an Oncology Center of Excellence at the Food and Drug Administration, which will coordinate and review all of FDA cancer treatments.
Under the existing review system, companies submit products to different divisions of the agency depending on whether it is a drug, device or biologic, a drug made from living cells. A treatment that combines a drug and a diagnostic device could get reviewed on different timelines.
The “Cancer Moonshot” initiative was announced by President Barack Obama at his State of the Union address in January.
Biden outlined a slew of other collaborations and initiatives, including making it easier for patients to find and enter clinical trials through the creation of a cancer trials website and making it easier for scientists to focus on research and less on raising money.
For the full Reuters story, click here.